← All trials
NCT04711291
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 11, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Jul 1, 2023
- First posted
- Jan 15, 2021
- Last posted
- Jan 19, 2021
- Enrollment
- 66
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Harvard UniversityLead sponsor
- Veloxis PharmaceuticalsCollaborator
- Harvard UniversityOverall official - principal investigator
- Harvard UniversityReponsible party - principal investigator
- Harvard UniversityStudy chair
- Harvard UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.